Akeso's IL-4Rα/ST2 Bispecific Antibody Cleared for Seven Phase II Studies in China Spanning Respiratory and Autoimmune Indications

Akeso, Inc. (9926.HK) is pleased to announce that the National Medical Products Administration has approved the initiation of ...